PolyPeptide Group AG (PPGN) — Financial Flexibility Index
PolyPeptide Group AG (PPGN) has a Financial Flexibility Index of 0.22x as of June 2025. Free cash flow of CHF98.34 Million (operating CF CHF49.66 Million minus capex CHF48.68 Million) represents 0% of total liabilities (CHF442.08 Million). Check PPGN strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PolyPeptide Group AG Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for PolyPeptide Group AG across 7 annual periods. See working capital position of PolyPeptide Group AG to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for PolyPeptide Group AG (2018–2024)
Year-by-year free cash flow to debt coverage for PolyPeptide Group AG. For the full company profile including market capitalisation, see PPGN stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | CHF176.37 Million | CHF89.40 Million | CHF399.33 Million | ▲ +45.9% |
| 2023 | 0.30x | CHF93.22 Million | CHF36.48 Million | CHF307.86 Million | ▼ -44.6% |
| 2022 | 0.55x | CHF84.22 Million | CHF5.46 Million | CHF154.10 Million | ▼ -29.6% |
| 2021 | 0.78x | CHF135.06 Million | CHF57.35 Million | CHF173.87 Million | ▲ +71.0% |
| 2020 | 0.45x | CHF90.10 Million | CHF49.48 Million | CHF198.31 Million | ▼ -6.0% |
| 2019 | 0.48x | CHF75.31 Million | CHF55.60 Million | CHF155.73 Million | ▲ +59.6% |
| 2018 | 0.30x | CHF41.24 Million | CHF22.94 Million | CHF136.15 Million | — |